Exabis Library
Welcome to the e-CCO Library!
P356: Czech experience with treatment of Crohn´s disease perianal fistulas by allogenic mesenchymal stem cell
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P356: Efficacy and safety of certolizumab pegol in Crohn’s disease patients with loss of response or intolerance to previous anti-TNF
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P356: Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in paediatric patients with inflammatory bowel disease: a multi-centre cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P356: The role of endoscopic activity in the coagulation profile of clinical remission Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P356: Treatment with anakinra induces T cell production of IL22 and GI mucosal healing in an IL-10RA mutation patient
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P357 Importance of stool drug monitoring in anti-TNF-treated patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P357: A multi-institutional report of postoperative outcomes in Vedolizumab-Treated patients undergoing major abdominal operations for inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P357: Do you think that complementary and alternative medicine use is frequent amongst inflammatory bowel disease patients: Forget it!—results from a comparative study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P357: Healthcare and medication utilisation in Singapore adult inflammatory bowel disease patients receiving immunomodulators and biologics
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P357: Intestinal ultrasound as a promising non-invasive monitoring tool in patients with Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P357: Long-term outcomes of biologic therapy in Crohn’s disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P357: Monitoring of Thiopurines and Methotrexate in Inflammatory Bowel Disease: Are we Monitoring Too Frequently? A Cross Sectional Study.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P357: Serological biomarkers of interstitial matrix and basement membrane remodelling correlate to disease activity in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P358 Predictors of response to faecal microbiota transplantation in patients with active ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P358: An observational, prospective cohort study to evaluate the long term safety and effectiveness of intravenous CT-P13 (biosimilar of infliximab) in patients with Crohn’s Disease or Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P358: Efficacy of golimumab for the treatment of ulcerative colitis patients in clinical practice: a retrospective cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P358: Factors associated with disability in inflammatory bowel disease (IBD): A cross-sectional study in outpatients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P358: Keeping it simple: How a streamlined referrals process reduces the time taken to initiate biologic therapy
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P358: Long-term clinical outcomes of intestinal Behçet's disease: a 30-year cohort study at a tertiary hospital in South Korea
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P358: Six-year adalimumab efficacy in steroid-dependent Crohn’s disease patients: a prospective ‘real-life’ study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM